CD99 Drives Terminal Differentiation of Osteosarcoma Cells by Acting as a Spatial Regulator of ERK 1/2†

Differentiation therapy is an attractive treatment for osteosarcoma (OS). CD99 is a cell surface molecule expressed in mesenchymal stem cells and osteoblasts that is maintained during osteoblast differentiation while lost in OS. Herein, we show that whenever OS cells regain CD99, they become prone t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Bone Miner Res
Main Authors: Sciandra, Marika, Marino, Maria Teresa, Manara, Maria Cristina, Guerzoni, Clara, Grano, Maria, Oranger, Angela, Lucarelli, Enrico, Lollini, Pier-Luigi, Dozza, Barbara, Pratelli, Loredana, Di Renzo, Maria Flavia, Colombo, Mario Paolo, Picci, Piero, Scotlandi, Katia
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2014
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4255300/
https://ncbi.nlm.nih.gov/pubmed/24677094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2141
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados